Drug Information

Drug General Information
Drug ID
D02VSP
Former ID
DNCL003820
Drug Name
MK-7655
Drug Type
Small molecular drug
Indication Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] Phase 2 [550004]
Company
Merck
Structure
Download
2D MOL

3D MOL
Formula
C12H20N4O6S
Canonical SMILES
C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3
InChI
1S/C12H20N4O6S/c17-11(14-8-3-5-13-6-4-8)10-2-1-9-7-15(10)12(18)16(9)22-23(19,20)21/h8-10,13H,1-7H2,(H,14,17)(H,19,20,21)/t9-,10+/m1/s1
InChIKey
SMOBCLHAZXOKDQ-ZJUUUORDSA-N
PubChem Compound ID
44129647
PubChem Substance ID
84982177, 89927678, 123055439, 138900123, 194173991, 194945547, 198940782, 205190636, 224548119, 229712298, 243335046, 251974399
Target and Pathway
Target(s) Beta-lactamase Target Info Inhibitor [532629]
References
Ref 550004Clinical pipeline report, company report or official report of Merck (May 7, 2015).
Ref 532629Discovery of MK-7655, a beta-lactamase inhibitor for combination with Primaxin?. Bioorg Med Chem Lett. 2014 Feb 1;24(3):780-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.